The pharmaceutical supply chain is constantly exposed to the threat of counterfeit products or incorrect storage and distribution of products, which is of serious concern in both developed and developing countries. To mitigate this risk, every activity in the distribution of pharmaceutical products should be carried out according to the principles of good storage practice (GSP) and good distribution practice (GDP) as applicable.

Some of the activities of the organization that are reviewed include

• Organization and management
• Personnel competence
• Resources; premises, warehousing, vehicles and equipment
• Importation; documentation, shipment containers & container labelling
• Dispatch and receipt
• Transportation and products in transit
• Packaging and re-labelling
• Returned products and complaints
• Contract activities
• Self-Inspection